Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Functional Food Ingredients Market 

5.1. COVID-19 Landscape: Functional Food Ingredients Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Functional Food Ingredients Market, By Type

8.1. Functional Food Ingredients Market, by Type, 2022-2030

8.1.1. Probiotics

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Proteins & amino acids

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Phytochemicals & plant extracts

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Prebiotics

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Functional Food Ingredients Market, By Source

9.1. Functional Food Ingredients Market, by Source, 2022-2030

9.1.1. Natural

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Animal

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Microbial

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Plant

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Synthetic

9.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Functional Food Ingredients Market, By Product 

10.1. Functional Food Ingredients Market, by Product, 2022-2030

10.1.1. Maltodextrin

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Probiotics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Polydextrose

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Modified Starch

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Functional Food Ingredients Market, By Health Benefits

11.1. Functional Food Ingredients Market, by Health Benefits, 2022-2030

11.1.1. Gut health

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cardiovascular health

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Bone health

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Immunity

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Nutritive health

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Weight management

11.1.6.1. Market Revenue and Forecast (2017-2030)

11.1.7. Others

11.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Functional Food Ingredients Market, By Application

12.1. Functional Food Ingredients Market, by Application, 2022-2030

12.1.1. Food

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Beverages

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Personal Care

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Pharmaceuticals

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Animal Feed

12.1.5.1. Market Revenue and Forecast (2017-2030)

12.1.6. Others

12.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Functional Food Ingredients Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.2. Market Revenue and Forecast, by Source (2017-2030)

13.1.3. Market Revenue and Forecast, by Product (2017-2030)

13.1.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.1.5. Market Revenue and Forecast, by Application (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.1.7. Market Revenue and Forecast, by Application (2017-2030) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.1.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.1.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.1.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.1.8.5. Market Revenue and Forecast, by Application (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.4. Market Revenue and Forecast, by Health Benefits (2017-2030) 

13.2.5. Market Revenue and Forecast, by Application (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.7. Market Revenue and Forecast, by Health Benefits (2017-2030) 

13.2.8. Market Revenue and Forecast, by Application (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.10. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.2.11. Market Revenue and Forecast, by Application (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.2.13. Market Revenue and Forecast, by Application (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Source (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.2.15. Market Revenue and Forecast, by Application (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.5. Market Revenue and Forecast, by Application (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.7. Market Revenue and Forecast, by Application (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.9. Market Revenue and Forecast, by Application (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.10.5. Market Revenue and Forecast, by Application (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Source (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.3.11.5. Market Revenue and Forecast, by Application (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.5. Market Revenue and Forecast, by Application (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.7. Market Revenue and Forecast, by Application (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.9. Market Revenue and Forecast, by Application (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.10.5. Market Revenue and Forecast, by Application (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Source (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.4.11.5. Market Revenue and Forecast, by Application (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.2. Market Revenue and Forecast, by Source (2017-2030)

13.5.3. Market Revenue and Forecast, by Product (2017-2030)

13.5.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.5.5. Market Revenue and Forecast, by Application (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Source (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.5.7. Market Revenue and Forecast, by Application (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Source (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Health Benefits (2017-2030)

13.5.8.5. Market Revenue and Forecast, by Application (2017-2030)

Chapter 14. Company Profiles

14.1. Archer Daniels Midland Company

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Ingredion Incorporated

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Golden Grain Group Limited

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. FMC Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Omega Protein Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. NutriBiotic

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Cargill Incorporated

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Tate & Lyle plc

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Roquette Frères

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms